United Imaging Healthcare Reports Remarkable 2025H1 Financial Growth with Record Overseas Revenue

United Imaging Healthcare's 2025H1 Financial Report

United Imaging Healthcare, a prominent player in advanced medical imaging and radiotherapy equipment, has reported its exceptional financial performance for the first half of 2025. The company has witnessed a remarkable year-over-year increase in both revenue and net profit, underlining its robust growth trajectory and successful overseas expansion.

During the first six months of 2025, United Imaging's revenue peaked at CNY 6.02 billion, marking a 12.79% increase compared to the same period in the previous year. Additionally, the net profit attributable to ordinary shareholders, after adjusting for non-recurring expenses, reached CNY 0.97 billion, reflecting a 21.01% rise. This growth can largely be attributed to the continuous rollout of innovative high-end products, in addition to significant strides made in international markets.

The overseas revenue has notably surged to CNY 1.14 billion, accounting for 18.99% of the overall revenue. Meanwhile, service revenues reached CNY 0.82 billion, also achieving a record high of 13.56% of total revenue. This demonstrates the increasing demand for United Imaging's advanced solutions across various regions, particularly in North America and Europe.

Investments in Research and Development (R&D) are critical for United Imaging's innovation efforts. The company allocated CNY 1.14 billion in R&D expenses during this period, an increase of 12.09% from the previous year. These investments focus on developing next-generation platform technologies and core product innovations. Overall, the company has rolled out over 140 innovative products globally, with 53 products cleared by the U.S. FDA and 57 receiving CE certifications.

The excitement around United Imaging's offerings is palpable, especially with more than 20 AI-enabled medical devices now authorized by the FDA. Some standout products include the uCT ATLAS Astound and uMR Jupiter, which facilitate more efficient and accurate imaging procedures.

In the first half of the year, several groundbreaking products were introduced. The uMR Ultra is setting new standards in soft-tissue diagnostics through high-definition imaging capabilities. Furthermore, the uCT SiriuX promises advancements in imaging technology with its unique gantry design, although it is still pending FDA clearance.

In addition to these developments, the uAngio AVIVA, which has received FDA clearance, boasts industry-first intelligent voice-assist technology that allows for hands-free operation during medical procedures, demonstrating United Imaging's commitment to leveraging AI for enhanced medical workflows.

The global demand for advanced medical equipment continues to expand, with United Imaging's overseas orders remaining notably strong, particularly for premium products. The company has established a robust presence in North America, with its premium imaging equipment installed in over 70% of U.S. states, resulting in more than 400 installations by mid-2025.

Furthermore, the company's stronghold in Europe is evidenced by its successful installations across more than 20 countries, such as the UK, Germany, and Italy. In Asia-Pacific and Latin America, key breakthroughs have been achieved with installations at top-tier medical facilities, including Singapore General Hospital, recognized as one of the leading hospitals in Asia.

Looking ahead, United Imaging Healthcare is committed to broadening its global reach and enhancing the delivery of premium medical equipment. The company also aims to sharpen its focus on AI innovation to promote the integration of intelligent, precise solutions within the realm of medical imaging equipment. This strategic direction is expected to significantly contribute to improved efficiency and accuracy in the global healthcare landscape.

As United Imaging Healthcare moves forward, it is set to reinforce its position as a leader in the medical imaging sector, with an unwavering focus on technology advancement to meet the growing demands of healthcare providers worldwide.